In prostate cancer, high preoperative serum Caveolin-1 levels have been established as a biochemical predictor of cancer progression and recurrence[87], suggesting a poor prognosis (shorter time to cancer recurrence). This evidence concerns the gene CAV1 and prostate cancer.